Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess

Journal of the National Cancer Institute

Volumn 88, Issue 15, 1996, Pages 1046-1052

  Ward, Elizabeth M ^a   Sabbioni, Gabriele ^b   DeBord, D Gayle ^a   Teass, Alexander W ^a   Brown, Kenneth K ^a   Talaska, Glenn G ^c   Roberts, Dennis R ^a   Ruder, Avima M ^a   Streicher, Robert P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLANILINE; 4 BIPHENYLAMINE; ANILINE; AROMATIC AMINE; HEMOGLOBIN;

ADULT; AIR MONITORING; ARTICLE; BIOLOGICAL MONITORING; BLADDER CANCER; CONTROLLED STUDY; DRUG URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RUBBER INDUSTRY; UNITED STATES;

EID: 0029779274     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.15.1046     Document Type: Article

References (34)

1. Ward E, Carpenter A, Markowitz S, Roberts D, Halperin W. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline [see comment citations in Medline]. J Natl Cancer Inst 1991;83:501-6.
2. Some aromatic amines, anthraquinones and nitroso compounds, and inorganic fluorides used in drinking-water and dental preparations. IARC Monogr Eval Carcinog Risk Chem Hum 1982;27:1-341.
3. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. Suppl 7. IARC Monogr Eval Carcinog Risk Chem Hum, 1987.
4. 1 mice. Washington (DC): US Govt Print Off, 1988. DHHS Publ No. (NIH)88-2588.
5. 1 mice. Washington (DC): US Govt Print Off, 1989. DHHS Publ No. (NIH)90-2821.
6. Melick WF, Naryka JJ, Kelly RE. Bladder cancer due to exposure to paraaminobiphenyl: a 17-year followup. J Urol 1971;106:220-6.
7. Dutkiewicz T, Piotrowski J. Experimental investigations on the quantitative estimation of aniline absorption in man. Pure Appl Chem 1961;3:319-23.
8. Dutkiewicz T. Absorption of aniline vapors in men. In: Proceedings of the 13th International Congress on Occupational Health. New York: Book Craftsmen Association, 1961:681-6.
9. Cheever KL, Richards DE, Plotnick HB. Metabolism of ortho-, meta-, and para-toluidine in the adult male rat. Toxicol Appl Pharmacol 1980;56:361-9.
10. Son OS, Everett DW, Fiala ES. Metabolism of o-[methyl-14C]toluidine in the F344 rat. Xenobiotica 1980;10:457-68.
11. Tannenbaum SR. Bladder cancer in workers exposed to aniline [letter] [see comment citation in Medline]. J Natl Cancer Inst 1991;83:1507-8.
12. Ward E, Dankovic DA. Bladder cancer in workers exposed to aniline [letter, response]. J Natl Cancer Inst 1991;83:1508.
13. Freudenthal RI, Anderson DP. A re-examination of the cause of excess bladder cancers in chemical plant workers [letter] [see comment citation in Medline]. J Natl Cancer Inst 1994;86:59-62.
14. Ward EM, Roberts D, Danokovic D, Flesch J, Reed L, Fajen J. A re-examination of the cause of excess bladder cancers in chemical plant workers [letter, response], J Natl Cancer Inst 1994;86:60-2.
15. Stillwell WG, Bryant MS, Wishnok JS. GC/MS analysis of biologically important aromatic amines. Application to human dosimetry. Biomed Environ Mass Spectrom 1987;14:221-7.
16. Skipper PL, Bryant MS, Tannenbaum SR. Determination of human exposure to carcinogenic aromatic amines from hemoglobin adducts in selected population groups. In: King CM, Romano LJ, Schuetzle D, editors. Carcinogenic and mutagenic responses to aromatic amines and nitroarenes. Proceedings of the Third International Conference on Carcinogenic and Mutagenic N-substituted Aryl Compounds, held April 25-28, 987, Dearborn, MI. New York: Elsevier, 1988.
17. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 1987;47:602-8.
18. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A 1988;85:9788-91.
19. Maclure M, Katz RB, Bryant MS, Skipper PL, Tannenbaum SR. Elevated blood levels of carcinogens in passive smokers [see comment citation in Medline]. Am J Public Health 1989;79:1381-4.
20. Tannenbaum SR, Bryant MS, Skipper PL, Maclure M. Hemoglobin adducts of tobacco-related aromatic amines: application to molecular epidemiology. Banbury Report 1986;23:63-75.
21. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, et al. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers [see comment citation in Medline]. J Natl Cancer Inst 1993;85:474-8.
22. Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper P, et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers [see comment citation in Medline]. J Natl Cancer Inst 1990;82:1826-31.
23. Falter B, Kutzer C, Richter E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin Investig 1994;72: 364-71.
24. Sabbioni G, Beyerbach A. Determination of hemoglobin adducts in humans. J Chromatogr B Biomed Appl 1995;667:75-83.
25. OSHA analytical methods manual. Cincinnati (OH): American Conference of Governmental Industrial Hygienists; Publ No. 4542, vol 3, Method No. 73, 1990.
26. Brown KK, Teass AW, Simon S, Ward EM. A biological monitoring method for o-toluidine and aniline in urine using high performance liquid chromatography with electrochemical detection. Appl Occup Environ Hyg 1995;10:557-65.
27. Homung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990;5:46-51.
28. US Department of Labor, Occupational Safety and Health Administration, Occupational Safety and Health Standards, Code of Federal Regulations Title 29, Chapter XVII, Part 1910, Subpart Z, Section 1910.1000, January 19, 1989.
29. el-Bayoumy K, Donahue JM, Hecht SS, Hoffmann D. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res 1986;46:6064-7.
30. Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD, editors. Harrison's principles of internal medicine. 9th ed. New York: McGraw-Hill, 1980.
31. Schulte PA, Ringen K, Hemstreet GP, Ward E. Occupational cancer of the urinary tract. Occup Med 1987;2:85-107.
32. Birner G, Neumann HG. Biomonitoring of aromatic amines II: hemoglobin binding of some monocyclic aromatic amines. Arch oxicol 1988;62:110-5.
33. Sabbioni G. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation. Chem Biol Interact 1992;81:91-117.
34. National Institute for Occupational Safety and Health. NIOSH alert: preventing bladder cancer from exposure to o-toluidine and aniline. Washington (DC): US Govt Print Off, 1990. DHHS/NIOSH Publ No. 90-116.